StemCell Institute (7096) Financial Statements

0 Followers

StemCell Institute Financial Overview

StemCell Institute's market cap is currently ¥6.80B. The company's EPS TTM is ¥24.46; its P/E ratio is 42.96; StemCell Institute is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	¥ 2.81B	¥ 2.68B	¥ 2.48B	¥ 2.09B	¥ 1.78B
Gross Profit	¥ 1.71B	¥ 1.69B	¥ 1.58B	¥ 1.34B	¥ 1.11B
Operating Income	¥ 202.66M	¥ 418.51M	¥ 413.76M	¥ 297.56M	¥ 226.95M
EBITDA	¥ 359.42M	¥ 695.19M	¥ 534.00M	¥ 402.49M	¥ 309.47M
Net Income	¥ 155.92M	¥ 385.80M	¥ 310.98M	¥ 198.03M	¥ 133.73M
Balance Sheet
Cash & Short-Term Investments	¥ 2.83B	¥ 3.20B	¥ 2.85B	¥ 3.32B	¥ 3.51B
Total Assets	¥ 8.12B	¥ 7.52B	¥ 6.59B	¥ 5.83B	¥ 5.23B
Total Debt	¥ 473.81M	¥ 518.96M	¥ 10.78M	¥ 5.89M	¥ 0.00
Net Debt	¥ -2.36B	¥ -2.68B	¥ -2.83B	¥ -3.32B	¥ -3.51B
Total Liabilities	¥ 5.05B	¥ 4.89B	¥ 3.90B	¥ 3.53B	¥ 3.13B
Stockholders' Equity	¥ 2.68B	¥ 2.63B	¥ 2.69B	¥ 2.30B	¥ 2.10B
Cash Flow
Free Cash Flow	¥ -335.78M	¥ -10.11M	¥ 132.97M	¥ 39.77M	¥ 264.81M
Operating Cash Flow	¥ 73.51M	¥ 467.69M	¥ 334.63M	¥ 99.67M	¥ 469.29M
Investing Cash Flow	¥ -337.92M	¥ -259.08M	¥ -811.77M	¥ -285.10M	¥ 404.17M
Financing Cash Flow	¥ -175.09M	¥ 146.70M	¥ -1.33M	¥ -869.00K	¥ 644.37M

Currency in JPY

StemCell Institute Earnings and Revenue History

Income Statement >

StemCell Institute Debt to Assets

Balance Sheet >

StemCell Institute Cash Flow

Cash Flow >

StemCell Institute Forecast EPS vs Actual EPS

Earnings >